Premium
Outgoing SAMHSA administrator on confidentiality, MAT and more
Author(s) -
Knopf Alison
Publication year - 2020
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32920
Subject(s) - confidentiality , methadone , buprenorphine , flexibility (engineering) , human services , psychology , medicine , political science , psychiatry , management , law , receptor , opioid , economics
In a far‐ranging interview with Elinore McCance‐Katz, M.D., Ph.D., outgoing assistant secretary of the Department of Health and Human Services, ADAW last week learned about the rationale for the most recent final rule on 42 CFR Part 2, the confidentiality regulation regarding substance use disorder (SUD) treatment, the future of flexibility for methadone and buprenorphine rules, what she views as top achievements of the past four years and more.